Cardiac rhythm management system with arrhythmia classification and electrode selection

• US 8,639,330 B2
• Filed: 05/14/2010
• Issued: 01/28/2014
• Est. Priority Date: 12/20/2001
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Spinelli, Julio C., Zhu, Qingsheng, Stahmann, Jeffrey E., Kramer, Andrew P.
• Primary Examiner(s): Schaetzle, Kennedy
• Application Number:
  US12/780,079
• Publication Number:
  US 20100222835A1
• Time in Patent Office: 1,355 Days
• Field of Search: None
• US Class Current: 607/14
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

A system, method, or device classifies an arrhythmia according to the temporal order in which a depolarization wave associated with a particular heart contraction is received at a plurality of electrodes. One or more antiarrhythmia therapies is mapped to each arrhythmia classification. When a particularly classified arrhythmia is detected, the correspondingly mapped therapy list is selected and an appropriate antiarrhythmia therapy delivered. In one example, the particular therapy delivered in response to an arrhythmia depends at least in part on its historical success in treating arrhythmias of that classification.

Claims

1. An implantable cardiac rhythm management device, comprising:

a plurality of electrodes, at least a first electrode of the plurality of electrodes configured to electrically couple to a first ventricle and at least a second electrode of the plurality of electrodes configured to electrically couple to a second ventricle;

an energy output circuit, coupled to the first and the second electrodes and configured to deliver electrical energy to the first and second ventricles via the first and second electrodes;

an arrhythmia detection circuit configured to detect a ventricular tachyarrhythmia episode; and

a processor coupled to the arrhythmia detection circuit and configured to control the energy output circuit to deliver anti-tachyarrhythmia pacing (ATP) therapy to the first and second ventricles via the first and second electrodes, wherein delivery of the ATP therapy includes pacing a primary ATP site and pacing at least one secondary ATP site during each cardiac cycle using an ATP offset interval between the primary ATP site and the secondary ATP site, the ATP offset interval based on a time delay between an intrinsic depolarization at the primary ATP site and an intrinsic depolarization at the secondary ATP site during ventricular tachyarrhythmia.

2. The device of claim 1, wherein the processor is configured to determine a pacing site that depolarizes earliest during the ventricular tachyarrhythmia and to designate the earliest depolarizing site as the primary ATP site and to designate other pacing sites as secondary ATP sites.

3. The device of claim 1, wherein the primary ATP site is associated with the first ventricle and the secondary ATP site is associated with the second ventricle.

4. The device of claim 1, wherein each pacing pulse delivered to the primary ATP site is delivered at a specified coupling interval relative to detection of an intrinsic depolarization at the primary ATP site.

5. The device of claim 1, wherein the processor is configured to control the energy output circuitry to deliver cardiac resynchronization pacing therapy including pacing the first and second ventricles using a resynchronization offset interval and to deliver the ATP therapy upon detection of the tachyarrhythmia episode.

6. The device of claim 5, wherein the resynchronization offset interval is different from the ATP offset interval.

7. The device of claim 1, wherein the primary ATP site is associated with the first ventricle and the secondary ATP site is associated with the second ventricle and the processor is configured to control the energy output circuitry to transition from delivering ATP therapy using the ATP offset interval to delivering cardiac resynchronization pacing therapy using the resynchronization offset interval after the ventricular tachyarrhythmia episode is terminated.

8. The device of claim 1, wherein the ATP offset interval is programmable.

9. The device of claim 1, wherein the time delay is measured by the cardiac device.

10. The device of claim 1, wherein the ATP offset interval is less than or equal to a minimum measured value of the time delay.

11. A method of operating an implantable cardiac rhythm management device, comprising:

detecting a ventricular tachyarrhythmia episode; and

delivering ATP therapy to first and second ventricles including delivering a pacing pulse to a primary ATP site and delivering a pacing pulse to the at least one secondary ATP site during one or more cardiac cycles of the tachyarrhythmia episode, the pacing pulse to the primary ATP site and the pacing pulse to the at least one secondary ATP site separated by an ATP offset interval, wherein the ATP offset interval is based on a time delay between an intrinsic depolarization of the primary ATP site and an intrinsic depolarization of the at least one secondary ATP site during ventricular tachyarrhythmia.

12. The method of claim 11, further comprising:

determining a pacing site that depolarizes earliest during cardiac cycles of the ventricular tachyarrhythmia;

designating the earliest depolarizing site as the primary ATP site; and

designating a later polarizing site as the secondary ATP site.

13. The method of claim 11, wherein the primary ATP site is associated with the first ventricle and the at least one secondary ATP site is associated with the second ventricle.

14. The method of claim 11, wherein delivering the ATP therapy comprises delivering the pacing pulse to the primary ATP site at a specified coupling interval relative to detection of an intrinsic depolarization at the primary ATP site.

15. The method of claim 11, further comprising delivering cardiac resynchronization pacing therapy including pacing the first and second ventricles using a resynchronization offset interval after delivering the ATP therapy.

16. The method of claim 15, wherein the resynchronization offset interval is different from the ATP offset interval.

17. The method of claim 11, wherein the primary ATP site is associated with the first ventricle and the secondary ATP site is associated with the second ventricle, and further comprising gradually transitioning from pacing the primary and secondary ATP sites using the ATP offset interval to pacing the first and second ventricles using the resynchronization offset interval.

18. The method of claim 11, further comprising programming the time delay into the cardiac device.

19. The method of claim 11, further comprising measuring the time delay using the implantable cardiac device.

20. The method of claim 11, wherein the ATP offset interval is less than or equal to a minimum measured value of the time delay.